We have shown that PI polyamides targeting TGF-β1 effectively improved renal sclerosis with hypertension [7,8] and diabetic nephropathy in rats [9] and progressive renal diseases in the primate common marmoset [10]. This evidence concerns the gene TGFB1 and diabetic kidney disease.